問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberBAY 94-8862 / 14564

2013-07-15 - 2016-01-30

Phase II

Terminated5

ICD-10I50.1

Left ventricular failure

ICD-9428.1

Left heart failure

  • Trial Applicant

    BAYER TAIWAN COMPANY LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator Chern-En Chiang 教學研究部

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator WEN-JONE CHEN Division of Emergency Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 徐國基 Division of General Internal Medicine

Co-Principal Investigator

  • 陳隆景 Division of Cardiovascular Diseases
  • 洪惠風 Division of Cardiovascular Diseases
  • 邱俊仁 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator 翁國昌 醫學教育

Co-Principal Investigator

  • 蔡青峰 Division of Cardiovascular Diseases

The Actual Total Number of Participants Enrolled

0 Completed

Principal Investigator Yen-Wen Wu Division of Cardiovascular Diseases

Co-Principal Investigator

  • 邱昱偉 Division of Cardiovascular Diseases
  • 林俊忠 Division of Cardiovascular Diseases
  • 張藝耀 Division of Cardiovascular Diseases
  • 黃竣暘 Division of Cardiovascular Surgery
  • 邱冠明 Division of Cardiovascular Surgery
  • 杜宗明 Division of Cardiovascular Diseases
  • 柯欣榮 Division of Cardiovascular Diseases
  • 黃日新 Division of Cardiovascular Surgery
  • 廖本智 Division of Cardiovascular Diseases
  • 陳運淇 Division of Cardiovascular Diseases
  • 劉芫宏 Division of Cardiovascular Diseases
  • 黃姍惠 Division of Cardiovascular Surgery
  • 許榮城 Division of Cardiovascular Diseases
  • 林恆旭 Division of Cardiovascular Diseases
  • 陳哲伸 Division of Cardiovascular Surgery

The Actual Total Number of Participants Enrolled

0 Completed

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    48 participants

  • Global

    1510 participants